Request an appointmentat Mayo Clinic
Diagnosed with stage 4 non-Hodgkin's lymphoma, Hendriks tackled treatment and training with positivity and persistence and is now cancer-free.
Dr. Mohamed Kharfan Dabaja discusses who is eligible for CAR-T cell therapy, the treatment process and its potential side effects.
Paula Quinn didn't know if she'd ever ride horses again after treatment for an aggressive form of non-Hodgkin's lymphoma damaged her heart. But a transplant gave her a second chance.
Jerry Haines and his wife Sherry find comprehensive care and a cure for Jerry's diffuse large B-cell lymphoma at Mayo Clinic.
Dr. Muhamad Alhaj Moustafa explains the different types of lymphoma, how they are treated, and the importance of seeking care from a lymphoma specialist.
Dr. Andrew Feldman and his team are helping to redefine the classification of T-cell lymphomas, an often fatal group of immune system tumors.
Hematologist Dr. Stephen Ansell discusses the different treatment options for lymphoma.
Researchers found that the addition of brentuximab vedotin to standard chemotherapy improves overall survival in people with Hodgkin Lymphoma.
A recent study investigates the reasons for decreasing remission rates for patients with non-Hodgkin lymphoma treated with CAR-T cell therapy.
Hematologist Dr. Carrie Thompson discusses what people can expect after treatment for lymphoma and how to achieve the best quality of life.